Document is current
Any future updates will be listed below
-
Authors
Vareli, Aimilia https://orcid.org/0000-0001-7272-8007
Vaidehi Narayanan, Haripriya https://orcid.org/0000-0001-8220-0724
Clark, Heather https://orcid.org/0009-0003-8043-617X
Jayawant, Eleanor https://orcid.org/0000-0003-2193-5414
Zhou, Hui
Liu, Yi https://orcid.org/0000-0002-2303-6212
Kennedy, Emma
Stott, Lauren https://orcid.org/0009-0005-9400-6642
Simoes, Fabio https://orcid.org/0000-0001-7630-0091
Hoffmann, Alexander https://orcid.org/0000-0002-5607-3845
Pepper, Andrea https://orcid.org/0000-0001-9795-1280
Pepper, Chris
Mitchell, Simon https://orcid.org/0000-0003-1091-6349
- License Information
-
More Information
Article History
Received: 4 February 2025
Revised: 26 June 2025
Accepted: 4 August 2025
First Online: 16 August 2025
COMPETING INTERESTS
: YL is a shareholder of DeepKinase Biotechnologies.
: All methods were performed in accordance with the relevant guidelines and regulations. Animal work was performed according to guidelines from the University of California, Los Angeles under approved ARC protocols (B-14-110 for breeding and R-14-126 for experiment).
